London, UK -- (SBWIRE) -- 11/15/2018 -- Analyst Speak:

"The Small Animal Diagnostics Market is projected to grow at notable CAGR over six years of forecast period 2018-2023 due to adoption of innovative and portable imaging systems, increased awareness regarding veterinary imaging techniques coupled with increased disposable income across the globe''.

Precision Business Insights (PBI) in its report titled "Small Animal Diagnostics Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2023" assesses the market performance over six years forecast period from 2018 to 2023. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

Sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/small-animal-diagnostic-imaging-system-market/#ulp-4H8Z4LpNMLEuOnnx

The Small Animal Diagnostics market accounted for US$ 2.57 Bn in 2018 and projected to reach US$ 4.35 Bn by 2023 due to increasing awareness of non-invasive technologies in veterinary practice. Availability of low-dose radiography systems, low exposure of pets and veterinary professionals to radiations is an advantage of novel diagnostic imaging systems.

Small Animal Diagnostics market segmented on the basis of modality, product, end-user and country

Portable devices are expected to dominate the market

Based on modality type, small animal diagnostics market is segmented into Portable, Stand-alone. The portable imaging devices are more convenient to the veterinary doctors and pets. These advantages of these devices over the conventional imaging devices, created demand for portable imaging devices.

Based on imaging device type, small animal diagnostics market is segmented into the MRI, Ultrasound, PET, Magnetic Particle Imaging, SPECT, CT, Photoacoustic Imaging, and Optical Imaging. The MRI and PET are expected to account for major revenue share in future

Based on end-user type small animal diagnostics market segmented into veterinary hospitals, veterinary clinics, others (research institutes). Veterinary hospitals are projected to be dominate the market share.

TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/small-animal-diagnostic-imaging-system-market/#ulp-c654SbFYO64MsOhu

Europe Accounted for Major Market Share for Small Animal Diagnostics Market

Precision Business Insights (PBI) Small Animal Diagnostics market report analyses the market in different regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa. According to regional analysis, Favorable government policies in Europe are expected to accelerate the small animal diagnostic imaging system market over the coming years. Increase training centers in imaging and adoption of advanced technologies are anticipated to fuel the market over the forecast timeframe. Saudi Arabia has the world's highest proportion of big dog breed; more than 70% of dog breeds are belonging to larger breeds. Increasing adoption of pets is expected to create demand for diagnostic imaging market. Brazil small animal diagnostic imaging system creates lucrative opportunities over the forecast period. Increasing pet adoption, availability of state-of-art technologies, increasing small animal per capita are expected to boost the market. More than 68% of New Zealand households own a pet, higher than any other nation across the globe. Emerging nations are expected to offer growth opportunities for global small animal diagnostic imaging system market.

Key player's profiles in the report are Orchard Softwares, IDEXX Laboratories, Inc., E-soat, CHISON, BCF Technology, ECM Echo, ontrol Medical, PRO Med, SIUI, Clarius, AnaSonic, RICSO, and SUOER among others.

Ask Analyst for Full Information about this report @
https://www.precisionbusinessinsights.com/market-reports/small-animal-diagnostic-imaging-system-market/#ulp-14mlyhjMGhVjZqa3

Detailed Segmentation

By Modality Type

o Portable
o Stand-alone

By Product Type

o MRI
o Ultrasound
o PET
o Magnetic Particle Imaging
o SPECT
o CT
o Photoacoustic Imaging
o Optical Imaging

By End-User
o Veterinary Hospitals
o Veterinary Clinics
o Others

Geography

o North America
? U.S.
? Canada

o Europe
? Germany
? UK
? France
? Russia
? Spain
? Italy
? Rest of Europe

o Asia-Pacific
? China
? Japan
? India
? ASEAN
? Rest of Asia Pacific

o Latin America
? Brazil
? Mexico
? Argentina
? Chile
? Rest of Latin America

o Middle East and Africa
? South Africa
? Saudi Arabia
? Rest of MEA

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/small-animal-diagnostic-imaging-system-market/

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Contact Person: Rajesh Babu
Role: Marketing Lead
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

London, UK -- (SBWIRE) -- 11/15/2018 -- Global Sports Nutrition Market was Valued at US$ 45.27 Bn in 2017, Surge in Demand for Nuritional Products from Athletes and Sports Persons
Analyst Speak:

"The Global Sports Nutrition Market was valued around US$ 45.27 Bn by 2017 and growing at a significant CAGR over seven years forecast period 2018-2024 owing to grow in demand for the nutritional products from athletes and sports persons"

Precision Business Insights (PBI) in its report titled "Global Sports Nutrition Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024" assesses the market performance over seven years forecast period over 2018-2024. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

The global sports nutrition market was valued at US$ XX Mn in 2017 and increasing at a significant CAGR over the forecast timeframe owing to surge in the adoption of nutritional supplements by athletes around the globe. Moreover, rise in number of fitness centers and health clubs, grow in awareness about the protein diet among the athletes, and better availability of the products are expected to drive the global sports nutrition market. However, high cost for the nutritional products, false perceptions and misleading claims about the products, and availability of alternate products for sports nutrition are anticipated to deter the revenue share of global sports nutrition market.

Sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/sports-nutrition-market/#ulp-4H8Z4LpNMLEuOnnx

Global sports nutrition market segmented on the basis of product type, distribution channel, and region

Energy Drinks Dominate the Global Sports Nutrition Market

Based on the product type, global sports nutrition market segmented into energy drinks, powders, juices, capsules and tablets, and other sports nutrition products. Energy drinks dominated the global sports nutrition market in 2017 and estimated to dominate over the forecast period owing to rise in promotion of energy drinks as a healthier alternative to aerated drinks, mental and physical benefits associated with the drinks are projected to surge the market over the forecast years.

North America Leads the Global Sports Nutrition market

PBI's global sports nutrition market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America accounted for larger revenue share through 2013-2017 and expected to dominate over 2018-2024 owing to surge in the rise in adoption of nutritional products by athletes and sports persons, grow in number of sports clubs, increase in disposable income, and launch of newer products are propel the market. Asia Pacific sports nutrition market projected to exhibit significant growth due to strong economic growth rate in emerging countries such as India, and China among others.

TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/sports-nutrition-market/#ulp-c654SbFYO64MsOhu

Novel Packaging's, Different Formulations and Marketing Campaigns are the key strategies adopted by market players

Global sports nutrition market further reveals that the key players increasingly adopting strategies such as novel packaging's, different formulations, product launches and marketing campaigns to improve market revenue share and gaining significant geographic presence across the region. For instance. In Feb 2017, Fonterra's dairy ingredients business introduced new whey protein ingredient for sports nutrition

Key player's profiles in the report are Abbott Nutrition Inc. (U.S.), The Coca-Cola Company (U.S.), PepsiCo Inc. (U.S.), Reckitt Benckiser Group plc. (U.K.), Glanbia Plc. (Ireland), Yakult Honsha Co Ltd (Japan), Otsuka Pharmaceuticals Co., Ltd. (Japan), GlaxoSmithKline plc. (U.K.), Atlantic Multipower UK Limited (U.K.), Olimp Laboratories (Poland), PowerBar Europe GmbH (Germany), and Ultimate Nutrition Inc. (U.S.)

Ask Analyst for Full Information about this report @
https://www.precisionbusinessinsights.com/market-reports/sports-nutrition-market/#ulp-14mlyhjMGhVjZqa3

Detailed Segmentation

By Product Type
o Energy Drinks
o Powders
o Juices
o Capsules and Tablets
o Bars

By Distribution Channel
o Retail Pharmacies
o Drug Specialty Stores
o Fitness Stores
o Supermarkets/Hypermarkets
o E-commerce

Geography
o North America
- U.S
- Canada

o Europe
- Germany
- France
- U.K
- Italy
- Spain
- Russia
- Poland
- Rest of Europe

o Asia-Pacific
- Japan
- China
- India
- Australia & New Zealand
- ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
- South Korea
- Rest of Asia-Pacific

o Latin America
- Brazil
- Mexico
- Argentina
- Venezuela
- Rest of Latin America

o Middle East and Africa (MEA)
- Gulf Cooperation Council (GCC) Countries
- Israel
- South Africa
- Rest of MEA

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/sports-nutrition-market/

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Contact Person: Rajesh Babu
Role: Marketing Lead
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

London, UK -- (SBWIRE) -- 11/14/2018 -- Analyst Speak:

"The Global Female Fertility Drugs Market was growing at a significant CAGR over seven years forecast period 2018-2024 owing to rise in the prevalence of infertility condition"

Precision Business Insights (PBI) in its report titled "Global Female Fertility Drugs Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 - 2017 and Forecast 2018-2024" assesses the market performance over seven years forecast period over 2018-2024. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

The global female fertility drugs market was growing at a significant CAGR over the forecast period owing to rise in the prevalence of infertility cases due to change in the lifestyle, government initiatives for the infertility management, and increase in disposable income are driving the female fertility drugs market over the forecast period. Moreover, rise in R&D activities for the development of novel drugs to treat the infertility conditions, rise in prevalence of obesity, and increase in the maternal age are expected to boost the female fertility drugs market. However, stringent regulatory policies for new drug approvals, lack of awareness regarding female fertility drugs in low economic countries, and alternative infertility treatments such as in vitro fertilization are restraining the growth of the global female fertility drugs market over forecast years.

Sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/female-fertility-drugs-market/#ulp-4H8Z4LpNMLEuOnnx

Global female fertility drugs market segmented on the basis of drug type, distribution mode, and route of administration, distribution channel and region

Gonadotropins Female Fertility Drugs Accounted For Higher Revenue Share

Based on drug type, global female fertility drugs market segmented into gonadotropins, aromatase inhibitors, selective estrogen receptor modulators, follicle stimulating hormones, dopamine agonists, metformin hydrochloride and others. Gonadotropins segment accounted for larger revenue share in 2017 and projected to dominate over the forecast period owing to rise in the prevalence of infertility cases. Moreover, mergers & acquisitions, collaborations, product developments and product launchings are the major strategies followed by the companies to increase their market revenue share in the female fertility drugs market.

North America leads the Global Female Fertility Drugs market

PBI's global female fertility drugs market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. According to regional analysis, North America accounted for larger revenue share in 2017 and the same trend is projected to follow over 2018-2024 owing to increase in the prevalence of female infertility rate due to obesity and lifestyle changes, increase in R&D activities for the innovation of novel molecules, and rise in awareness about the fertility drugs among the stakeholders in the region. Europe female fertility drugs market projected to exhibit significant growth due to accessibility and increase in infertility rate in female due to hormonal imbalance, and lifestyle changes are the factors that are creating lucrative opportunities in the European region for female fertility drugs market players.

TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/female-fertility-drugs-market/#ulp-c654SbFYO64MsOhu

Product approvals, launch of new products and strategic alliances are the key strategies adopted by the market players

Global female fertility drugs market further reveals that the key player's increasingly adopting strategies such as product launch and long term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance, in May 2017, Merck KGaA received European Commission Grants approval for Pergoveris prefilled injection used in the treatment of follicle stimulating hormone (FSH) and Luteinizing hormone (LH) deficiency.

Key player's profile in the report are Sanofi S.A. (France), Merck KGaA (Germany), Novartis AG (Switzerland), Ferring B.V. (Switzerland), Berlex Laboratories Inc. (U.S.), Eli Lilly and Co. (U.S.), Novogyne Pharmaceuticals (U.S.), and Pfizer, Inc. (U.S.).

Ask Analyst for Full Information about this report @
https://www.precisionbusinessinsights.com/market-reports/female-fertility-drugs-market/#ulp-14mlyhjMGhVjZqa3

Detailed Segmentation

By Drug Type
o Gonadotropins
o Aromatase Inhibitors
o Selective Estrogen Receptor Modulators
o Follicle Stimulating Hormones
o Dopamine Agonists
o Metformin Hydrochloride
o Others

By Distribution Mode
o Prescription Fertility Drugs
o Over-The-Counter Fertility Drugs

By Route of Administration
o Oral
o Parenteral

By Distribution Channel
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
Geography

o North America
- U.S
- Canada

o Europe
- Germany
- France
- U.K
- Italy
- Spain
- Russia
- Poland
- Rest of Europe

o Asia-Pacific
- Japan
- China
- India
- Australia & New Zealand
- Rest of Asia-Pacific

o Rest of World
- Brazil
- South Africa
- Saudi Arabia
- Others

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/female-fertility-drugs-market/

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Contact Person: Rajesh Babu
Role: Marketing Lead
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Pharmaceutical Intermediates Market is Expected to Pegged around US$ 32,180 Mn by 2023, Due to Surge in Pharma Production Coupled with Increased Exports of API

London, London -- (SBWIRE) -- 11/10/2018 -- Analyst Speak:

"The Pharmaceutical Intermediates Market is anticipated to reach about US$ 32,180 Mn by 2023, and anticipated to expand at a CAGR over six years of forecast period 2018-2023 owing to surge in the production of pharmaceuticals coupled with the increased exports of APIs.

Precision Business Insights (PBI) in its report titled "Pharmaceutical Intermediates Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2023" assesses the market performance over six years forecast period from 2018 to 2023. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

The Pharmaceutical Intermediates market size was accounted for US$ 26,457.0 Mn in 2018 and anticipated to account for US$ 32,180.0 Mn by 2023. Increased prevalence of chronic diseases will create demand for novel active pharmaceutical ingredients (API). Surge in the pharmaceutical production enables stimulate the demand for pharmaceutical intermediates. Moreover, Escalated exports of APIs will also enhance the demand for pharmaceutical intermediates.

Sample of this report is available upon request:
https://www.precisionbusinessinsights.com/market-reports/pharmaceutical-intermediates-market/#ulp-4H8Z4LpNMLEuOnnx

Pharmaceutical Intermediates market segmented on the basis of application, end-user and country

Cardiovascular Drugs Segment Expected to Dominate the Market

Based on Application Type, The Pharmaceutical Intermediates market is segmented as anti-infective drugs, cardiovascular drugs, central nervous system drugs, anti-diabetic drugs, anti-ulcerants, and others. Cardiovascular drugs segment has been witnessed to account for major revenue share over the forecast period. The API intermediates are raw materials which are responsible for therapeutic action. These can be converted into the desired formulations such as capsules, tablets, and others.

Pharmaceutical Companies Will Dominate the Revenue Share.

Based on end-user type, pharmaceutical intermediates market segmented into pharmaceutical companies, research laboratories, contract manufacturing organizations, and others. The pharmaceutical companies are witnessed to account for major revenue share over the forecast period.

Asia-Pacific, Accounts for Major Revenue Share for Pharmaceutical Intermediates Market

Precision Business Insights (PBI) Pharmaceutical Intermediates market report analyses the market in different regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa. According to regional analysis, Asia Pacific accounted for major revenue share due to increased R&D investments in China and India. Surge in the pharmaceutical production coupled with increased exports are witnessed to offer lucrative opportunities for the market players plunged in the pharmaceutical intermediates market.

U.S. Pharmaceutical Intermediates market is accounted for major revenue share in North America, owing to increased pharmaceutical production and robust investments in R&D.

TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/pharmaceutical-intermediates-market/#ulp-c654SbFYO64MsOhu

Strategic Collaborations & Exports Play Vital Role in Pharmaceutical Intermediates Market

The increased R&D investment from pharmaceutical companies, research organizations and biotech companies are expected to create demand for pharmaceutical intermediates. Key player's profiles in the report are Aceto Corporation, BASF SE, Vertellus Holdings LLC, Lianhetech, Easter Chemical Corporation, Cycle Pharma Chem, Dishman Group, Dextra Laboratories Limited, Chemcon Specialty Chemical Pvt. Ltd, Midas Pharma GmbH, Codexis, A.R. Life Sciences Private Limited, Sanofi Winthrop Industries, and ZCL Chemical Ltd among others.

Ask Analyst for Full Information about this report @
https://www.precisionbusinessinsights.com/market-reports/pharmaceutical-intermediates-market/#ulp-14mlyhjMGhVjZqa3

Detailed Segmentation

By Application Type

o Anti-Infective Drugs
o Cardiovascular Drugs
o Central Nervous System Drugs
o Anti-diabetic Drugs
o Anti-Ulcerants
o Others

By End-User Type

o Pharmaceutical Companies
o Research Labs
o Contract Manufacturing Organizations
o Other Industries

Geography

o North America
? U.S.
? Canada

o Europe
? Germany
? UK
? France
? Russia
? Spain
? Italy
? Rest of Europe

o Asia-Pacific
? China
? Japan
? India
? ASEAN
? Rest of Asia Pacific

o Latin America
? Brazil
? Mexico
? Argentina
? Chile
? Rest of Latin America

o Middle East and Africa
? South Africa
? Saudi Arabia
? Rest of MEA

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/pharmaceutical-intermediates-market/

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Contact Person: Rajesh Babu
Role: Marketing Lead
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Veterinary Vaccines Market Projected to be Account for around US$ 11,100 Mn by 2023 Due to Outbreak of Pandemic Diseases and Increased Production of Farm Animals

London, London -- (SBWIRE) -- 11/10/2018 -- Analyst Speak:

"The Veterinary Vaccines Market has projected to account for US$ 11,100 Mn by 2023, witnessed to expand at significant CAGR over six years of forecast period 2018-2023 due to burgeoning the prevalence of pandemic diseases coupled with the increased poultry production across the globe''.

Precision Business Insights (PBI) in its report titled "Veterinary Vaccines Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2023" assesses the market performance over six years forecast period from 2018 to 2023. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

The Veterinary Vaccines market was valued at US$ 8,400 Mn in 2018 and projected to reach US$ 11,100 Mn by 2023 due to rapid expansion of pandemic diseases, increased production of livestock across the globe and increased R&D investments in the veterinary vaccines to offer the novel solutions.

Sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-veterinary-vaccines-market/#ulp-4H8Z4LpNMLEuOnnx

Veterinary Vaccines market segmented on the basis of product, animal, and country

Inactivated Live Vaccines Expected to Dominate the Market

The veterinary vaccines market is segmented by product type i.e., Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines. The inactivated vaccines segment is witnessed to account for major market share over the forecast period due to increased demand for inactivated vaccines.

Based on animal type veterinary vaccines market segmented into cattle, canine, feline, poultry, and swine. Poultry vaccines are expected to gain traction over the forecast period owing to increased poultry production across the globe, increased demand for meat.

TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-veterinary-vaccines-market/#ulp-c654SbFYO64MsOhu

North America Accounted for Major Market Share for Veterinary Vaccines Market

Precision Business Insights (PBI) Veterinary Vaccines market report analyses the market in different regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa. According to regional analysis, North America accounted for major revenue share through 2012-2017 and is anticipated to continue the leverage over 2018-2023 owing to high awareness of animal diseases and transmission to humans, increased R&D in veterinary vaccines arena, launch of novel products in North America market coupled with rise in demand for poultry farms and cattle farms.

U.S. veterinary vaccines market is accounted for major revenue share in North America, owing to increased adoption of pets. Increased veterinary spending coupled with state-of-art healthcare technologies in country are expected to foster the market size in future.

Robust R&D Investments In Order to Offer Novel Animal Vaccines

The market players are increased R&D investment in animal vaccines to provide innovative solutions to treat the pandemic diseases. Key player's profiles in the report are Merck & Co., Phibro Animal Health Corp., Hester Biosciences Ltd, Zoetis Animal Healthcare, Eli Lilly & Company, Virbac, Ceva Sante Animale, Boehringer Ingelheim Animal Health GmbH, and HIPRA among others.

Ask Analyst for Full Information about this report @
https://www.precisionbusinessinsights.com/market-reports/global-veterinary-vaccines-market/#ulp-14mlyhjMGhVjZqa3

Detailed Segmentation

By Product Type

o Attenuated Live Vaccines
o Inactivated Vaccines
o Subunit Vaccines
o DNA Vaccines
o Recombinant Vaccines

By Animal Type

o Cattle
o Canine
o Feline
o Poultry
o Swine

Geography

o North America
? U.S.
? Canada

o Europe
? Germany
? UK
? France
? Russia
? Spain
? Italy
? Rest of Europe

o Asia-Pacific
? China
? Japan
? India
? ASEAN
? Rest of Asia Pacific

o Latin America
? Brazil
? Mexico
? Argentina
? Chile
? Rest of Latin America

o Middle East and Africa
? South Africa
? Saudi Arabia
? Rest of MEA

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-veterinary-vaccines-market/

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Contact Person: Rajesh Babu
Role: Marketing Lead
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Digital Therapeutics Market To Be Valued US$ XX Mn by 2023 Due to Surge in Chronic Diseases Coupled with Adoption of Innovative Technologies

London, London -- (SBWIRE) -- 11/10/2018 -- Analyst Speak:

"The Digital Therapeutics Market has witnessed to reach US$ XX Mn by 2023, set to grow with a significant CAGR over six years of forecast period 2018-2023 owing to increase in prevalence of chronic diseases and increased awareness among the patients regarding the advanced technologies".

Precision Business Insights (PBI) in its report titled "Digital Therapeutics Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2023" assesses the market performance over six years forecast period from 2018 to 2023. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

The Digital Therapeutics market was valued at US$ XX Mn in 2018 and projected to reach US$ XX Mn by 2023 owing to increase demand for health and social care with soaring geriatric population coupled with burgeoning the prevalence of chronic diseases and co-morbidities.

Sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/digital-therapeutics-market/#ulp-4H8Z4LpNMLEuOnnx

Digital Therapeutics market segmented on the basis of application, distribution channel, and country

Increased Adoption of Digital Technologies for Patient Care

Surge in the number of mobile health care applications, increased digital health efficacy, increased number of sensors enables bring new health uses witnessed to unlock the potential of the digital therapeutics market.

Based on application type digital therapeutics market segmented into Prevention (Prediabetes, Obesity) Care (Diabetes, CNS, CVD, Musculoskeletal, Smoking Cessation, Others). Distribution Channel B2B (Provider, Payer, Employer) B2C (patient, Caregiver).

Based on Application, diabetes is projected to expand at significant growth rate due to increased diabetes patient pool and adoption of novel software to assist the patient to ensure the daily medications and blood measurement of glucose levels

TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/digital-therapeutics-market/#ulp-c654SbFYO64MsOhu

U.S., Most Lucrative Market for Digital Therapeutics Market

Precision Business Insights (PBI) Digital Therapeutics market report analyses the market in different regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa. According to regional analysis, North America accounted for larger revenue share through 2012-2017 and is projected to follow over 2018-2023 owing to increase in adoption of innovative technologies in patient care, rising the number of mobile and internet users. Increased number of geriatric population pool, obese and diabetic population in U.S., is anticipated to offer lucrative opportunities for the market players

Launch of new software, and strategic alliances are the key strategies adopted by market players

Digital Therapeutics market key players adopting strategies such as introduction of new products into the market, strategic collaborations among the players to strengthen the market position and gain the competitive edge is anticipated to fuel the market.

Key player's profiles in the report are Omada Health Inc.,WellDoc, Inc, 2Morrow, Inc., Livongo Health, Proteus Digital Health, Inc., Twine Health, Inc., Jintronix Inc., Canary Health, Inc., Propeller Health Noom Inc.,Virta Health Corp and Medtronic Plc., Dthera Sciencess., Claritas Mindsciences, BiogenoQ Inc.

Ask Analyst for Full Information about this report @
https://www.precisionbusinessinsights.com/market-reports/digital-therapeutics-market/#ulp-14mlyhjMGhVjZqa3

Detailed Segmentation

By Application Type
o Prevention
? Prediabetes
? Obesity

o Care
o Diabetes
o CNS
o CVD
o Musculoskeletal
o Others

By Distribution Channel
o B2B
? Providers
? Payers
? Pharmacies
? Others

o B2C
? Patient
? Care giver

Geography
o North America
? U.S.
? Canada

o Europe
? Germany
? UK
? France
? Russia
? Spain
? Italy
? Rest of Europe

o Asia-Pacific
? China
? Japan
? India
? ASEAN
? Rest of Asia Pacific

o Latin America
? Brazil
? Mexico
? Argentina
? Chile
? Rest of Latin America

o Middle East and Africa
? South Africa
? Saudi Arabia
? Rest of MEA

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/digital-therapeutics-market/

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Contact Person: Rajesh Babu
Role: Marketing Lead
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Global Non-Surgical Fat Reduction Market was valued around US$ XX Mn by 2017 and growing at a 6.2% CAGR over seven years forecast period 2018-2024 owing to grow in obese population globally.

London, London -- (SBWIRE) -- 11/10/2018 -- Analyst Speak:
"The Global Non-Surgical Fat Reduction Market was valued around US$ XX Mn by 2017 and growing at a 6.2% CAGR over seven years forecast period 2018-2024 owing to grow in obese population globally."

Precision Business Insights (PBI) in its report titled "Global Non-Surgical Fat Reduction Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024" assesses the market performance over seven years forecast period over 2018-2024. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

Obesity is a major problem in this fast-moving world. According to the World Health Organisation (WHO), in 2016 more than 1.9 billion adults, 18 years and older, were obese. Obesity is responsible for many deaths in the world. Hence, people are becoming health conscious and showing interest to remove their excess fat in their bodies. Earlier, a majority of the people used to go for the surgical way to reduce fat in their bodies.

Sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/non-surgical-fat-reduction-market/#ulp-4H8Z4LpNMLEuOnnx

Growing interest towards the minimal invasive procedures and increase in obese population are projected to dominate the market over the forecast period.
According to Precision Business Insights (PBI), introduction of new technologies into the market that can reduce the fat in a minimal invasive way gaining more attention from the consumers. Hence, non-surgical fat reduction market is projected to grow at a rapid pace when compared with the conventional surgical fat reduction. In the non-surgical fat reduction, it helps in reduction of fat in stubborn fat pockets, and body contours.

The non-surgical fat has more benefits when compared with surgical fat reduction such as faster healing time, minimal side effects, no scars and anesthesia. In the non-surgical fat reduction, it selectively breaks down the fat cells to remove the stubborn fat from areas such as abdomen, arms and thighs among others. Growing obese population and a minimal invasive procedure is driving the growth of the non-surgical fat reduction market over the forecast period. However, a high cost of the procedure and availability of treatment in fewer regions are projected to hamper the growth of non-surgical fat reduction market.

TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/non-surgical-fat-reduction-market/#ulp-c654SbFYO64MsOhu

The global non-surgical fat reduction market is divided into the following categories

Device
- Laser Surgery Devices
- Ultra Sound Devices
- RF Devices
- Others

End User
- Hospitals
- Beauty Clinics
- Others

Ask Analyst for Full Information about this report @
https://www.precisionbusinessinsights.com/market-reports/non-surgical-fat-reduction-market/#ulp-14mlyhjMGhVjZqa3

North America Market Projected To Dominates Non-Surgical Fat Reduction Market Over the Forecast Period
Non-surgical fat reduction market is becoming more popular in the North America market and projected to create huge market opportunities for the market players that are operating in this market owing to rise in demand for the non-invasive surgical procedures for reduction of fat and recent U.S. FDA approvals of new technologies such as SculpSure in the U.S. market. Furthermore, aesthetic market players are strategically moving by acquiring companies that are operating in the non-surgical fat reduction market. For instance, in April 2017, Allergan, a leader in the aesthetics, acquired ZELTIQ Aesthetics Inc., that involved in controlling fat reduction treatment, CoolSculpting. In March 2017, Hologic Inc. acquired Cynosure, Inc., a leading player in aesthetic systems and technologies.

Some of the market players in global non-surgical fat reduction market include ZELTIQ Aesthetics (Allergan plc) (Ireland), Alma Lasers, Ltd. (Israel), Sciton, Inc. (U.S.), Fotona (U.S.), Lynton Lasers Ltd. (UK), Venus Concept Canada Corp., Cynosure, Inc. (Hologic Inc.) (U.S.), Solta Medical Inc. (Thermage) (U.S.), Lutronic Corporation (South Korea), Syneron Medical Ltd. (U.S.).

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/non-surgical-fat-reduction-market/

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Contact Person: Rajesh Babu
Role: Marketing Lead
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

The Global Bladder Cancer Treatment Market was valued around US$ XX Mn by 2017 and growing at a significant CAGR over seven years forecast period 2018-2024 owing to grow in incidence of bladder cancer around the globe.

London, London -- (SBWIRE) -- 11/10/2018 -- Global Bladder Cancer Treatment Market was Valued at US$ XX Mn in 2017, Surge in Incidence of Bladder Cancer
Analyst Speak:

"The Global Bladder Cancer Treatment Market was valued around US$ XX Mn by 2017 and growing at a significant CAGR over seven years forecast period 2018-2024 owing to grow in incidence of bladder cancer around the globe."

Precision Business Insights (PBI) in its report titled "Global Bladder Cancer Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024" assesses the market performance over seven years forecast period over 2018-2024. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

The global bladder cancer treatment market was valued at US$ XX Mn in 2017 and increasing at a significant CAGR over the forecast timeframe owing to surge in the incidence of bladder cancer, technological advancements in the treatment procedure, launch of newer therapeutics for the treatment, government initiatives to prevent the cancer and advanced healthcare services are expected to drive the global bladder cancer treatment market. However, high cost for the treatment, asymptomatic nature of the disease, adverse effects associated with the chemotherapy and radiotherapy are anticipated to hinder the revenue share of global bladder cancer treatment market.

Sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-bladder-cancer-treatment-market/#ulp-4H8Z4LpNMLEuOnnx

Global bladder cancer treatment market segmented on the basis of cancer type, drug class, distribution channel, and region

Immunotherapy Dominates the Global Bladder Cancer Treatment Market

Based on the drug class, global bladder cancer treatment market segmented into chemotherapy and immunotherapy. Immunotherapy dominated the global bladder cancer treatment market in 2017 and estimated to dominate over the forecast period owing to innovation of newer therapeutics by the companies, rise in awareness about the bladder cancer among the people, and patent filings by the market players are driving the growth of the market over the forecast years. However, a slow growth rate observed for the chemotherapy drugs due to patent expirations and entry of generics into the market.

North America Leads the Global Bladder Cancer Treatment Market

PBI's global bladder cancer treatment market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America accounted for larger revenue share through 2013-2017 and expected to dominate over 2018-2024 owing to advance healthcare system, presence of skilled professionals with high awareness about the bladder cancer, launch of innovative drugs into market, and rise in healthcare expenditure are propel the market. Asia Pacific bladder cancer treatment market projected to exhibit significant growth due to entry of market players into emerging countries such as India and China and development in healthcare infrastructure are boost the market

TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-bladder-cancer-treatment-market/#ulp-c654SbFYO64MsOhu

Accelerated Approvals For The Drugs, and Favorable Reimbursement Scenario projected to drive the growth of the bladder cancer treatment market

Global bladder cancer treatment market players are actively investing on research and developments activities and providing assistance to the patient regarding their insurance coverage. Furthermore, favorable reimbursement scenario for the bladder cancer treatment drugs are driving the growth of the market. For instance. In 2017, AstraZeneca received U.S. FDA accelerated approval for Imfinzi (Durvalumab) for the treatment of bladder cancer

Key player's profiles in the report are AstraZeneca plc. (U.K.), Bristol-Myers Squibb (U.S.), Celgene Corporation (U.S.), Eli Lilly and Company (U.S.), Co., AbbVie Inc., (U.S.), F. Hoffmann-La Roche (Switzerland), GlaxoSmithKline plc. (U.K.), Novartis AG (Switzerland), Pfizer Inc.( U.S.), and Sanofi (France)

Ask Analyst for Full Information about this report @
https://www.precisionbusinessinsights.com/market-reports/global-bladder-cancer-treatment-market/#ulp-14mlyhjMGhVjZqa3

Detailed Segmentation

By Cancer Type
o Transitional cell bladder cancer
o Invasive bladder cancer
o Superficial bladder cancer
o Squamous cell bladder cancer
o Other rare types

By Drug Class
o Chemotherapy
o Alkylating agents
o Plant alkaloids
o Taxanes
o Anti-tumour Antibiotics
o Anti-metabolites
o Topoisomerase inhibitors
o Immunotherapy
o Tumor-targeting mAbs
o DC-Based immunotherapy
o Peptide- and DNA-based anticancer vaccines
o Immune stimulatory cytokines
o Immune modulatory mAbs
o Immuno suppressive metabolism Inhibitors
o Pattern recognition receptor Agonists
o Others

By Distribution Channel
o Hospital Pharmacies
o Retail Pharmacies
o Others

Geography
o North America
- U.S
- Canada

o Europe
- Germany
- France
- U.K
- Italy
- Spain
- Russia
- Poland
- Rest of Europe

o Asia-Pacific
- Japan
- China
- India
- Australia & New Zealand
- ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
- South Korea
- Rest of Asia-Pacific

o Latin America
- Brazil
- Mexico
- Argentina
- Venezuela
- Rest of Latin America

o Middle East and Africa (MEA)
- Gulf Cooperation Council (GCC) Countries
- Israel
- South Africa
- Rest of MEA

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-bladder-cancer-treatment-market/

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Contact Person: Rajesh Babu
Role: Marketing Lead
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Global Dermal Fillers Market was Valued at US$ 3.2 Bn in 2017, Due To Growing Demand For The Aesthetic Procedures

London, UK -- (SBWIRE) -- 11/09/2018 -- "The Global Dermal Fillers Market was valued around US$ 3.2 Bn by 2017 and growing at a significant CAGR over seven years forecast period 2018-2024 owing to grow in prevalence of dermatology cases"

Precision Business Insights (PBI) in its report titled "Global Dermal Fillers Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024" assesses the market performance over seven years forecast period over 2018-2024. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

The global dermal fillers market was valued at US$ 3.2 Bn in 2017 and increasing at a significant CAGR over the forecast timeframe due to surge in the incidence of various dermatological issues such as deep lines, wrinkles and scars in various countries around the world. Moreover, rise in number of aging population, increase in the demand for minimally-invasive or non-invasive surgical procedures, and technological advancements in the treatment procedures are expected to drive the global dermal fillers market. However, high cost for the dermatological treatment procedure and post-procedure complications are projected to hamper the revenue share of global dermal fillers market.

Sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-dermal-fillers-market/#ulp-4H8Z4LpNMLEuOnnx

Global dermal fillers market segmented on the basis of product type, ingredient type, distribution channel, and region

Hyaluronic Acid Dermal Fillers Dominate the Global Dermal Fillers Market

Based on the ingredient type, global dermal fillers market segmented into hyaluronic acid, poly-L-lactic acid, calcium hydroxylapatite, polymethylmethacrylate, collagen and others. Hyaluronic acid dermal fillers dominated the global market from past few years and estimated to dominate over the forecast period owing to rise in the adoption of hyaluronic acid derivatives due to their ability to attract the water molecules and helps in hydration of the skin. Furthermore, hyaluronic acid dermal fillers have less side effects when compared with the other dermal filler products. Moreover, launch of newer hyaluronic acid products into market also helps to enhance the revenue share in global dermal fillers market.

North America Leads the Global Dermal Fillers market

PBI's global dermal fillers market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America accounted for larger revenue share through 2013-2017 and expected to dominate over 2018-2024 owing to surge in the number of dermatological treatment procedures, rise in demand for non-invasive or minimally-invasive aesthetic procedures, increase in aged population, and growing healthcare expenditure are projected to propel the market. Europe dermal fillers market projected to exhibit significant growth due to rise in incidence of dermatology patients and rise in skin treatment applications are expected to bolster the market. Furthermore, countries like South Korea, China, and Brazil are projected to registered higher growth rates when compared with other countries.

TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-dermal-fillers-market/#ulp-c654SbFYO64MsOhu

Launch of newer products, novel indications and strategic alliances are the key strategies adopted by market players

Global dermal fillers market further reveals that the key players increasingly adopting strategies such as launch of newer products, novel indications and long term alliance to improve market revenue share and entering into the new markets. For instance. In 2015, Allergan plc, received approval from the U.S.FDA to market its juvederm ultra XC injection used for lip augmentation in adults over the age of 21.

Key player's profiles in the report are Galderma (Nestle) (Switzerland), Bioha Laboratories (China), Merz Pharma GmbH & CO. KGAA (Germany), Syneron Inc.(U.S.), Allergan plc (Ireland), AQTIS Medical (Canada), Teoxane Laboratories (Switzerland), Prollenium Medical Technologies Inc.,(U.S) and Suneva Medical (U.S.)

Ask Analyst for Full Information about this report @
https://www.precisionbusinessinsights.com/market-reports/global-dermal-fillers-market/#ulp-14mlyhjMGhVjZqa3

Detailed Segmentation

By Product Type
o Absorbable Dermal Fillers
o Non-Absorbable Dermal Fillers

By Ingredient Type
o Hyaluronic Acid (HLA)
o Poly-L-Lactic Acid (PLA)
o Calcium Hydroxylapatite (CaH)
o Polymethylmethacrylate (PMMA)
o Collagen
o Others

By Distribution Channel
o Retail Pharmacies
o Beauty Clinics
o Online Pharmacies

Geography
o North America
- U.S
- Canada

o Europe
- Germany
- France
- U.K
- Italy
- Spain
- Russia
- Poland
- Rest of Europe

o Asia-Pacific
- Japan
- China
- India
- Australia & New Zealand
- ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
- South Korea
- Rest of Asia-Pacific

o Latin America
- Brazil
- Mexico
- Argentina
- Venezuela
- Rest of Latin America

o Middle East and Africa (MEA)
- Gulf Cooperation Council (GCC) Countries
- Israel
- South Africa
- Rest of MEA

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-dermal-fillers-market/

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Contact Person: Rajesh Babu
Role: Marketing Lead
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Strong application of food enzymes in Food and Beverages industries for product standardization & uniformity and rise in awareness on health and nutrition in consumers are the key factors expected to witness 7.10% CAGR market growth rate during the forecast period 2018-2025.

London, UK -- (SBWIRE) -- 11/07/2018 -- The global food enzymes market is estimated to be valued USD 2.35 Bn in 2018 and is anticipated to reach USD 3.99 Bn by 2025, at a CAGR of 7.10% during the forecast period.

Precision Business Insights (PBI) in its report titled "Global food enzymes market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 and Forecast 2018-2025" assesses the market performance over eight years forecast period over 2018-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

Free sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/food-enzymes-market/#ulp-4H8Z4LpNMLEuOnnx

Market boosts and restraining factors:
Increasing demand from dairy, fermentation industry, meat processing and alcoholic beverages for various application of food enzymes and rise in adoption of packaged food products by the consumers are major driving factors in food enzymes market. Owing to technology advancements in various food industries in the preparation of new foods is an also a confirmatory factor to for growth of digestive enzymes (Supplements) market. Moreover, increasing population with food requirements across the globe and rise in awareness on healthy diet among population and consumption rate are also expected to witness rise in market value of digestive enzymes market over the forecast period.
The global food enzymes market has been segmented into type of enzyme, source, application and geographical regions.

North America region has largest market share in terms of value in the global food enzymes market
Trend to witness high adoption of packaged food and beverages products, well regulated food and drinks industries and healthy food intake habits among people are expected to increase North America market share during the forecast period.

In Asia Pacific region, huge demand for diary products, packaged food, and beverages coupled with industrialization of food and beverages products with growing population are the major driving factors expected to register highest CAGR value over the forecast period.
Owing to presence of strong players in the Europe region, and their continues product launches in the market, and increasing demand for packaged food and meat products from the populations are the major market driving factors.

Market strategies and global players:
Product launches and merges, acquisitions & collaborations are the key strategies of market leaders in global food enzymes market. Market players present in global food enzymes market are engaged in development of the new whole foods market digestive enzymes and product launches for strengthening their digestive enzyme supplements market position. For instance, in November 2015, E. I. du Pont de Nemours and Company launched Powermill Enzyme, which reduces the wheat conditioning time up to 50% and reduces the consumption of energy up to 10%. Furthermore, companies operating in these market also focusing on mergers, acquisitions and collaborations as their key strategies to increase their market share. For instance, in August 2017, Advanced Enzymes Technologies acquired Evoxx Technologies GmbH to boost its market share in the market.

Ask Analyst for Full Information about this report @
https://www.precisionbusinessinsights.com/market-reports/food-enzymes-market/#ulp-14mlyhjMGhVjZqa3

Key players in global food enzymes market includes
- Novozymes A/S (Denmark)
- E. I. DuPont de Nemours and Company (U.S.)
- Associated British Foods plc (U.K.)
- Deerland Enzymes (U.S.)
- Dyadic International, Inc. (U.S.)
- Chr. Hansen A/S (Denmark)
- Koninklijke DSM N.V. (The Netherlands)
- Advanced Enzyme Technologies (India)
- Amano Enzyme Inc. (Japan)
- Puratos Group (Belgium)

Key development in the global food enzymes market
In 2013, Novoenzymes Inc. launched food enzyme product, "Acrylaway HihT" used to reduce the acrylamide in food.

Technological advancements and strategic alliances are the key strategies adopted by market players
Whole Foods Market Digestive Enzymes players such as E. I. DuPont de Nemours and Company (U.S.), Novozymes A/S (Denmark) & few others are focusing on untapped markets and geographies to capitalize the Digestive Enzyme Supplements market opportunities along with attaining significant market shares during the forecast period.

Free TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/food-enzymes-market/#ulp-c654SbFYO64MsOhu

Detailed segmentation
By Type of enzyme
- Proteases
- Lipases
- Carbohydrase
o Amylase
o Cellulose
o Pectinase
o Lactase

By Source
- Plant
- Animal
- Microorganisms

By Application
- Processed Food Industry
- Dairy
- Bakery
- Beverages

By Geographical regions
- North America
- Latin America
- Europe
- Asia-Pacific
- The Middle East & Africa

Key Features of the Report:

The report provides granular level information about the market size, regional market share, historic market (2013 to 2017) and forecast (2018 to 2025)
The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
The report tracks recent innovations, key developments and startup's details that are actively working in the market
The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market

Press Release:

https://www.precisionbusinessinsights.com/press-release/food-enzymes-market-research-analysis/
https://www.openpr.com/news/1296378/Food-Enzymes-Market-was-Valued-Around-2-35-Bn-in-2018-and-is-Expected-to-Reach-3-26-Bn-by-2023.html

About Precision Business Insights:

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,
152 – 160 City Road,
London EC1V 2NX

Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553

Website @www.precisionbusinessinsights.com

Kemp House, 152 – 160 City Road, London EC1V 2NX

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Global Food Hydrocolloids Market: By Source (Natural Source and Synthetic source), By Type (Agar, Gelatin, Alginate, Xanthan gum, Galactomannans, Starch, and Others), By Function (Fat Replacer, Emulsifier, Stabilizer, Coating Agents, and Others), By Application (Bakery, Confectionery, Dairy & Frozen Products, Beverages, and Others) By Distribution Channel (Supermarkets & Hypermarkets, Online Stores, and Others), and Geography.

London, UK -- (SBWIRE) -- 11/02/2018 -- Precision Business Insights (PBI) in its report titled "Global food hydrocolloids market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 and Forecast 2018-2025" assesses the market performance over eight years forecast period over 2018-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

Market boosts and restraining factors:

Soaring demand for the processed food is the key factor driving the growth of the food hydrocolloids market. The rising health awareness among the masses is anticipated to drive the market revenue growth. The ability to act as a substituent of fat in the food products and increasing research and development activities is adding scope for the expansion of the market which is providing opportunity to the vendors to expand the market presence.
However, the stringent government regulations are likely to hamper the growth of the food hydrocolloids market.

Free sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/food-hydrocolloids-market/#ulp-4H8Z4LpNMLEuOnnx

The global food hydrocolloids market is segmented based on the source, type, function, application, end-users and geographical regions.

North America holds the largest share in the global revenue share:

North America food hydrocolloids market is dominant market when compared with that of the other regional markets. The change in lifestyles along with soaring working population are keen towards the convenience food is the key factor anticipating the growth of the food hydrocolloids market in this region.
Europe trails North America. Asia Pacific is expected to grow exponentially in the forecasted period owing to its urbanization.
The interest of the vendors towards the emerging economies like China and India is likely to boost the growth of the market over the forthcoming years.

Some of the players in the global food hydrocolloids market include:
- Lubrizol Corporation (U.S)
- Kerry Group PLC. (Ireland)
- Darling Ingredients Inc. (U.S)
- Fuerst Day Lawson (UK)
- TIC GUMs Inc. (U.S)
- E. I. du Pont de Nemours and Company (U.S)
- Cargill, Inc. (U.S)
- CP Kelco (U.S)
- Ashland Inc. (U.S)

Key development in the global food hydrocolloids market
In June 2017, Alland & Robert has launched clean label hydrocolloid solution.

Free TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/food-hydrocolloids-market/#ulp-c654SbFYO64MsOhu

By Source
- Natural Source
o Plant
o Seaweed
o Microbial
o Animal
- Synthetic Source

By Type
- Agar
- Gelatin
- Alginate
- Xanthan Gum
- Galactomannans
- Starch
- Others

By Function
- Fat Replacer
- Emulsifier
- Stabilizer
- Coating Agents
- Others

By Application
- Bakery
- Confectionery
- Dairy & Frozen Products
- Beverages
- Others

By Distribution channels
- Supermarkets & Hypermarkets
- Online Stores
- Others

By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- The Middle East & Africa

Ask Analyst for Full Information about this report @
https://www.precisionbusinessinsights.com/market-reports/food-hydrocolloids-market/#ulp-14mlyhjMGhVjZqa3

Key Features of the Report:

- The report covers exhaustive regional information, that includes North America (the USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentian, Venezula, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa)
- The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2025)
- The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup's details that are actively working in the market
- The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/food-hydrocolloids-market/

About Precision Business Insights:
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX

Contact Person: Satya A
Role: Business Development Head
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

The Global Aquaculture Vaccines Market is forecasted to reach USD 664.4 Million by 2025 and projected to grow with a CAGR of 9.2% over the forecast period 2018-2025 owing to decrease in usage of antibiotics in aquaculture farms and high yield of fish with usage of vaccines when compared to the other pharmaceuticals.

London, London -- (SBWIRE) -- 10/24/2018 -- According to Precision Business Insights report, the global aquaculture market is growing with a rapid pace due to increase in consumption of fish as they are rich in protein. However, increase in bacterial and viral diseases are affecting the aquaculture market. Antibiotics are most commonly used to treat bacterial and viral infections in fish. However, growing antibiotic resistance became a big concern. Hence, aquaculture vaccines are gaining importance in the entire aquaculture ecosystem as they can improve the fish yield and protects the fishes from bacterial and viral infections.

Ask Analyst for Full Information about this report @https://www.precisionbusinessinsights.com/market-reports/global-aquaculture-vaccines-market/

Growing aquaculture production and restrictions on antibiotics usage in aquaculture will create lucrative opportunities for aquaculture vaccine manufacturers. Inactivated vaccines dominates the aquaculture vaccines market due to their established clinical efficacy and accessibility of the products when compared with the DNA vaccines and attenuated live vaccines. However, DNA vaccines are projected to exhibit significant growth over the forecast period as they provide strong immunity to the aqua species than conventional vaccines in the market. Market players are also actively working in developing newer vaccines to broaden the product portfolio. For instance, in 2017, Elanco launched DNA derived vaccine, Clynav, in Europe market.

Stringent regulations, lack of awareness about benefits associated with vaccines adoption and complexity in storage of vaccines are the main barriers for the aquaculture vaccines market growth. Furthermore, majority of the vaccines are the salmon based vaccines. Very few aquaculture vaccines are currently available in the market that can be used for other species.

Free sample of this report is available upon request @https://www.precisionbusinessinsights.com/market-reports/global-aquaculture-vaccines-market/

Europe dominates the global aquaculture vaccines market

PBI's global aquaculture vaccines market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Globally, Asia Pacific region is the leader in the aquaculture production however, antibiotics are most commonly used in Asia-pacific region when compared with the aquaculture vaccines. Europe accounted for larger revenue share through 2013-2017 and the trend is projected to follow over 2018-2025 owing to increase in the adoption of aquaculture vaccines in Norway, Russia, U.K, Greece, and other countries. Furthermore, European countries focus on salmon farming and majority of the commercial vaccines that are available in the market are salmon based vaccines.

Mediterranean aquaculture market is projected to register high CAGR for aquaculture vaccines over the forecast period owing to surge in aquaculture production. In Latin America, Chile dominates the aquaculture vaccines market when compared with the other countries. Chile is the second largest producer of salmon that stands next to Norway.

Aquaculture vaccines are administered through immersion, injection, and oral route. Injection method dominates the aquaculture vaccines market as they are more effective and provides significant protection to the fish when compared with other route of administration. However, injection route is tedious process and capital intensive process.

Very few market players operating in the global aquaculture vaccines market

Global aquaculture vaccines market is dominated by the top five players and they account for significant market share. Top animal health players are actively acquiring the fish vaccine companies to expand their product portfolio in the aquaculture market. Development of aquaculture vaccines other than salmon species could be seen as lucrative opportunity for the market players. Global aquaculture vaccines market report further reveals that the key players increasingly adopting strategies such as launch of newer products and long term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance. In January 2017, Pharmaq acquired fish vaccination company Nordland Sett Vaks to strengthen its fish vaccine portfolio. In addition, In May 2018, HIPRA launched its well-known ICTHIOVAC VR/PD vaccine, an injectable vaccine registered for sea bass against Vibriosis and Pasteurellosis in Turkish market.

Key market player's profiles that are covered in the report are Pharmaq AS (Zoetis, LLC) (Norway), Merck Animal Health (Merck & Co., Inc.) (U.S.), KoVax Ltd. (Israel), Virbac (France), Elanco (U.S.), Hipra (Spain), Tecnovax SA (Argentina), Veterquimica S.A. (Chile), and Nisseiken Co. Ltd. (Japan) among others

Free TOC of this report is available upon request @https://www.precisionbusinessinsights.com/market-reports/global-aquaculture-vaccines-market/

Detailed Segmentation

By Vaccine Type
o Inactivated Vaccine
o Attenuated Live Vaccine
o DNA Vaccine
o Others

By Application
o Bacterial Infection
o Viral Infection
o Combined Bacterial and Viral Infections
o Others

By Route of Administration
o Immersion Vaccines
o Injection Vaccines
o Oral Vaccines

By Species
o Salmon
o Seabass and Seabream
o Tilapia
o Trout
o Turbot
o Carp

Geography

o North America
- U.S
- Canada
o Europe
- Norway
- Russia
- United Kingdom
- Greece
- Spain
- Rest of Europe
o Asia-Pacific
- China
- Indonesia
- Bangladesh
- Philippines
- Rest of Asia-Pacific
o Latin America
- Chile
- Brazil
- Mexico
- Peru
- Rest of Latin America
o Middle East and Africa (MEA)
- Egypt
- Iran
- Turkey
- Uganda
- Rest of MEA

Get access to full summary @https://www.precisionbusinessinsights.com/market-reports/global-aquaculture-vaccines-market/

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX

Contact Person: Satya A
Role: Business Development Head
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

The Europe Beer market estimated to be valued 262,238.3 (000’ HL) in 2018 and set to expand at significant CAGR over 2018 to 2024.

London, UK -- (SBWIRE) -- 10/19/2018 -- Analyst Speak:

"The Europe Beer Market poised to reach US$ 163,453.1 Mn by 2024 with a significant CAGR over forecast period of 2018 to 2024 owing to increased number of micro-breweries to increase the production in order to meet the demand of beers, launch of new flavors across the Europe"

Precision Business Insights (PBI) in its report titled "Europe Beer Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024" assesses the market performance over seven years forecast period from 2018 to 2024. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

The Europe Beer market revenue was valued at US$ 131,525.7 Mn in 2018 and projected to reach US$ 163,453.1 Mn by 2024 owing to increased beer exports coupled with surge in number of breweries across the Europe. Surge in inclination towards flavored, low-alcohol beers are anticipated to increase demand for Europe beer market. However, high tax rates, stringent government regulations of advertisements are major road blocks for Europe Beer market over forecast years.

Ask Analyst for Full Information about this report @https://www.precisionbusinessinsights.com/market-reports/europe-beer-market/

Europe Beer market segmented on the basis of product type, by production type, by packaging type, and country

Ales are accounted for major revenue share in Europe beer market:

Based on product type, Europe Beer market segmented into stout & porter, larger, malt, ales, and others. Ales segment was accounted for major revenue share in 2018 and projected to dominate the market share over the forecast period owing to surge in demand for ales. Ales market revenue was pegged at US$ 45,661.3 Mn in 2017, set to grow at a CAGR of 4.5% over the forecast period. Larger, Stout & Porter expected to gain significant market share in near future due to increase adoption of larger, stout & porter.

Germany dominates the Europe beer market:

Precision Business Insights (PBI) Europe Beer market report analyses the market in different countries of Europe such as UK, France, Germany, Spain, Belgium, Netherlands, Sweden, Norway, Portugal, and Iceland. According to regional analysis, Germany beer market accounted for larger revenue share through 2013 to 2017 and continue the leverage over the forecasted period of 2018 to 2024 due to increased number of breweries, and surge in exports to European and non-European countries. Belgium beers have been gaining popularity due to it's supreme quality and unique flavors.

Free sample of this report is available upon request @https://www.precisionbusinessinsights.com/market-reports/europe-beer-market/

Surge in micro-breweries are anticipated to drive the Europe beer market:

Tremendous increase in micro-breweries are anticipated to drive the European beer market in future. The microbrewery segment accounted for US$ 74,566.4 Mn in 2017, and witnessed to grow around 3.0% CAGR over the forecast period. The Craft brewery segment accounted for 7.3% revenue share in 2017, and projected to reach 8.2% of revenue share by 2024.

Glass bottle packaging is dominated the market, with a share around 43.0% in 2017, and expected to dominate the market over the forecast timeframe. PET packaging segment expected to decline in future due to stringent regulations on PET packaging of beer.

Free TOC of this report is available upon request @https://www.precisionbusinessinsights.com/market-reports/europe-beer-market/

Detailed Segmentation

By Product Type
o Stout & Porter
o Larger
o Malt
o Ales
o Others

By Production Type
o Macro Brewery
o Micro Brewery
o Craft Brewery
o Others

By Packaging Type
o PET Bottle
o Metal Cans
o Glass Bottle
o Others

Geography
o Europe
- UK
- France
- Germany
- Spain
- Belgium
- Netherlands
- Sweden
- Norway
- Portugal
- Iceland

Get access to full summary @https://www.precisionbusinessinsights.com/market-reports/europe-beer-market/

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX

Contact Person: Satya A
Role: Business Development Head
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

The Europe Oncology Biosimilars Market poised to reach US$ 3.2 Bn by 2024 with a significant CAGR over seven years forecast period (2018-2024) owing to established approval procedures for biosimilars by EMA in Europe region.

London, UK -- (SBWIRE) -- 10/10/2018 -- Precision Business Insights (PBI) in its report titled "Europe Oncology Biosimilars Market: Market Size, Dynamics, Country Share, Trends, Competitor Analysis 2016-2017 and Forecast 2018-2024" assesses the market performance over seven years forecast period. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

The Europe oncology biosimilars market was valued at US$ XX Mn in 2017 and projected to reach US$ 3.2 Bn by 2024 owing to relatively greater adoption of biosimilars in European countries such as Germany, France, UK, Italy and Spain. Moreover, lower cost of biosimilars in comparison with biologics and increase in prevalence of chronic diseases driving the market growth. Growing physician awareness, distribution agreements, acceptance and launch of biosimilars are anticipated to propel the Europe oncology biosimilars market over the forecast period. However, uncertainty and reluctance of physicians to adopt biosimilars and time consuming approval process may hinder the growth of Europe oncology biosimilars market over forecast years.

Free sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/oncology-biosimilars-market/#ulp-4H8Z4Lp.

Europe Oncology Biosimilars market segmented on the basis of drug class, cancer type, indication, distribution channel and country

Based on drug class Europe oncology biosimilars market segmented into monoclonal antibodies (mAb), granulocyte colony ctimulating factor (G-CSF), and hematopoietic agents. Hematopoietic agents accounted for larger revenue share in 2017 and projected to lose market revenue share over the forecast period owing to cost reduction, launch of Filgrastim and Epoetin biosimilars. However, monoclonal antibodies (mAb) segment projected to exhibit lucrative growth is mainly attributed to the launch of Trastuzumab and Rituximab biosimilars in the Europe market.

Italy leads the Europe Oncology Biosimilars market

Precision Business Insights recently published report that provide detailed account of Europe oncology biosimilars market in different countries such as Germany, France, UK, Italy, and Spain. According to country analysis, Italy accounted for larger revenue share through 2016-2017 and the same trend is projected to follow over 2018-2024 owing to significant biosimilars acceptance. Germany and UK countries projected to exhibit significant growth owing to launch of mAb biosimilars in the market.

Free TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/oncology-biosimilars-market/#ulp-c654SbF.

Gaining regulatory approvals, collaboration for distribution of biosimilars are the key strategies adopted by market players

Europe oncology biosimilars market further reveals that the key players increasingly adopting strategies such as gaining regulatory approvals and collaboration for distribution of biosimilars to improve the market presence and gaining significant geographic presence across the region. For instance, in 2018, Celltrion has officially launched Trastuzumab biosimilar, Herzuma, for the treatment of patients with early breast cancer, metastatic breast cancer, or metastatic gastric cancer whose tumors have either HER2 overexpression or HER2 gene amplification. Company has granted Mundipharma exclusive distribution rights to the biosimilar in the United Kingdom, Germany, Italy, Belgium, Luxembourg, and the Netherlands.

Ask Analyst for Full Information about this report @
https://www.precisionbusinessinsights.com/market-reports/oncology-biosimilars-market/#ulp-14mlyhj.

Key player's profiles in the report are Sandoz International GmbH (Germany), Amgen Inc. (U.S.), Celltrion Healthcare Co., Ltd. (South Korea), Samsung Bioepis (South Korea), Pfizer Inc., (U.S) and Teva Pharmaceutical Industries Ltd. (Israel)

Detailed Segmentation

By Drug Class
- Monoclonal Antibodies (mAb)
- Granulocyte Colony Stimulating Factors (G-CSF)
- Hematopoietic Agents

By Cancer Type
- Blood Cancer
- Breast Cancer
- Others

By Indication
- Malignant Lymphoma or Multiple Myeloma
- HER2 Positive Metastatic Breast Cancer (MBC)
- Neutropenia
- Non-Hodgkin's Lymphoma (NHL)

By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies

By Country
- Germany
- France
- UK
- Italy
- Spain

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/oncology-biosimilars-market/

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Contact Person: Rajesh Babu
Role: Marketing Lead
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Global Optical Coherence Tomography Market was valued around US$ 735.3 Mn in 2017 and growing at a significant CAGR over ten years forecast period 2018-2027 owing to increase in the demand for non-invasive diagnostic methods

London, UK -- (SBWIRE) -- 05/23/2018 -- Precision Business Insights (PBI) in its report titled "Global Optical Coherence Tomography Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2027" assesses the market performance over 2018-2027. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

The global optical coherence tomography market was valued at US$ 735.3 Mn in 2017 and growing at a significant CAGR over the forecast period owing to increase in the aging population around the globe. Additionally, technological advancements in the optical coherence tomography such as high resolution, rise in prevalence of chronic diseases such as diabetic retinopathy, cardiovascular diseases, and certain types of cancers, and presence of favorable reimbursement policies are expected to propel the market. However, high cost for installation, product recalls, limited products for pediatric diagnosis, and lack of skilled professionals to operate these devices are expected to hinder the growth of global optical coherence tomography market over forecast years.

A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/optical-coherence-tomography-market/#ulp-4H8Z4LpNMLEuOnnx

Global optical coherence tomography market segmented on the basis of product type, application, technology, end user, and region

Ophthalmology segment accounted for higher revenue share
Based on application, global optical coherence tomography market segmented into ophthalmology, dermatology, and others. Ophthalmology segment accounted for larger revenue share in 2017 and projected to dominate over the forecast period owing to increase in the prevalence of diabetic retinopathy and ophthalmic disorders. However, dermatology segment projected exhibit lucrative growth, which is mainly attributed to rise in the incidence of skin cancers and technological advancements of optical coherence tomography devices.

North America leads the Global Optical Coherence Tomography market
PBI's global optical coherence tomography market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America accounted for larger revenue share through 2012-2017 and the same trend is projected to follow over 2018-2027 owing to increase in the preference for non-invasive diagnostic procedures, rise in geriatric population, and increase in federal investments for the development of OCT devices. Asia Pacific market projected to exhibit significant growth owing to large pool of aging population with ophthalmic related disorders.

To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/optical-coherence-tomography-market/#ulp-c654SbFYO64MsOhu

Launch of newer products, patent filings, and strategic alliances are the key strategies adopted by the market players
Global optical coherence tomography market further reveals that the key players increasingly adopting strategies such as launch of newer products, patent filings, and long term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance. Carl Zeiss filed exclusive rights to 71 patents and patent applications pertaining to OCT applications and Optovue has applied for 12 patents since 2009.

Key players profiled in the report are Carl Zeiss Meditec AG. (Germany), Leica Microsystems (Germany), Optovue, Incorporate. (U.S.), Heidelberg Engineering GmbH (Germany), Topcon Corporation (Japan), Tomophase, Inc. (U.S.), NIDEK CO., LTD. (Japan), Moptim Imaging Technique (China), Agfa-Gevaert Group (Belgium)

Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/optical-coherence-tomography-market/#ulp-14mlyhjMGhVjZqa3

Detailed Segmentation
By Product Type
- Portable/Handheld
- Table Top

By Application
- Ophthalmic Diagnosis
- Dermatology
- Others

By Technology
- Spectral Domain OCT
- Swept Source OCT

By End-User
- Hospitals
- Clinics
- Others

Geography
- North America
o US
o Canada

- Europe
o Germany
o France
o K
o Italy
o Spain
o Russia
o Poland
o Rest of Europe

- Asia-Pacific
o Japan
o China
o India
o Australia & New Zealand
o ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
o South Korea
o Rest of Asia-Pacific

- Latin America
o Brazil
o Mexico
o Argentina
o Venezuela
o Rest of Latin America

- Middle East and Africa (MEA)
o Gulf Cooperation Council (GCC) Countries
o Israel
o South Africa
o Rest of MEA

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/optical-coherence-tomography-market/

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI's approachable strategies are to help clients to make key decisions for business growth.

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Global Plaque Psoriasis Treatment Market poised to reach USD 20,388.2 Million by 2023 with a significant CAGR over the forecast period (2018-2023) owing to increase in prevalence of the psoriasis conditions all across the globe

London, UK -- (SBWIRE) -- 05/18/2018 -- Precision Business Insights (PBI) in its report titled "Global Plaque Psoriasis Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2023" assesses the market performance over six years forecast period. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

The global plaque psoriasis treatment market was valued at USD 11,411.7 Million in 2017 and projected to reach USD 20,388.2 Million by 2023 owing to increase in the prevalence of the psoriasis conditions all across the globe. Increase in awareness about the psoriasis conditions and active participation of non-profit organizations to bring awareness among the psoriasis patients about the new therapies are expected to drive the plaque psoriasis market. The novel treatments for plaque psoriasis and the co-pay programs are anticipated to propel the Global plaque psoriasis treatment market. However, high cost of plaque psoriasis treatment products and lack of disease awareness in underdeveloped countries are hinder the growth of global plaque psoriasis treatment market over forecast years.

Free sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/plaque-psoriasis-treatment-market/#ulp-4H8Z4LpNMLEuOnnx

Global Plaque Psoriasis Treatment market segmented on the basis of product type, route of administration, distribution channel, and country
Interleukin Inhibitors accounted for higher revenue share
Based on product type global plaque psoriasis treatment market segmented into Interleukin Inhibitors, Tumor Necrosis Factor (TNF), and others. Interleukin Inhibitors expected to account a significant revenue share in global plaque psoriasis treatment market with share of 32.4% (2018) in global market and projected to grow at 20.0% CAGR over 2018 and 2023.
North America leads the Global Plaque Psoriasis Treatment market
PBI's global plaque psoriasis treatment market report analyses the market in different regions such as North America, Europe, and rest of the world. According to regional analysis, The market for plaque psoriasis treatment estimated to be valued at US$ XX Mn in 2018 and poised to grow at 7.9% CAGR over the forecast period (2018 – 2023) owing to growing introduction of biologics in US market.

Free TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/plaque-psoriasis-treatment-market/#ulp-c654SbFYO64MsOhu

Licensing agreements, partnerships & collaboration strategic alliances are the key strategies adopted by market players

Global plaque psoriasis treatment market report further reveals that the key players increasingly adopting strategies such as licensing agreements, partnerships & collaboration to improve market revenue share and gaining significant geographic presence across the region. For instance In July 2017, Almirall and Sun Pharma has entered into a license agreement on the development and commercialization of tildrakizumab for psoriasis in Europe. Under terms of the license agreement, Sun Pharma will be eligible to receive development and regulatory milestone payments and, additionally, sales milestone payments and royalties on net sales. Almirall will be able to lead European studies, and participate in larger global clinical studies for psoriasis indication.
Key player's profiles in the report are Novartis AG (Switzerland), AbbVie Inc. (U.S), Amgen, Inc. (U.S), Johnson & Johnson (U.S), Eli Lilly and Company (U.S), Celgene Corporation (U.S), Sun Pharmaceuticals Industries Ltd. (India)
Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/plaque-psoriasis-treatment-market/#ulp-14mlyhjMGhVjZqa3

Detailed Segmentation

By Product Type
- Interleukin Inhibitors
? Tildrakizumab
? Guselkumab
? Ixekizumab
? Secukinumab
? Ustekinumab
? Brodalumab
- Tumor Necrosis Factor (TNF)
? Etanercept
? Adalimumab
? Infliximab
- Others

By Route of Administration
- Topical
- Parenteral
- Others

By Distribution Channel Type
- Hospital Pharmacies
- Retail Pharmacies
- Others

Geography
- North America
? The U.S
? Canada
- Europe
? Germany
? France
? UK
? Italy
? Spain
? Rest of Europe
- Rest of the world
? Japan
? China
? India
? Brazil
? Others

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/plaque-psoriasis-treatment-market/

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Global Turf and Ornamental Crop Protection Market poised to reach US$ 5,047.6 Million by 2023 with a significant CAGR over the forecast period (2018-2023) owing to increase in the number of golf courses and sports grounds

London, UK -- (SBWIRE) -- 05/18/2018 -- Precision Business Insights (PBI) in its report titled "Global Turf and Ornamental Crop Protection Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2023" assesses the market performance over the forecast period (2018-2023). The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

The global turf and ornamental crop protection market was valued at US$ 3,821.2 Million in 2017 and projected to reach US$ 5,047.6 Million by 2023 owing to increase in the number of golf courses and sports grounds throughout the world, for instance, In 2015, a total of 34,011 golf courses were identified worldwide. Additionally, many golf courses are under construction, driven by the popularity of the sports among athletes, rise in awareness about the maintenance of turf and ornamental grass, and rise in concerns about the usage of pesticides are anticipated to propel the global turf & ornamental crop protection market. However, high cost of the turf & ornamental crop protection products, stringent regulations to use of pesticides, and escalation in the adoption of artificial turf are hinder the growth of global turf and ornamental crop protection market over forecast years.

A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/turf-and-ornamental-crop-protection-market/#ulp-4H8Z4LpNMLEuOnnx

Global turf and ornamental crop protection market segmented on the basis of grass type, origin, product type, mode of application, and region

Turf grass accounted for higher revenue share
Based on grass type global turf and ornamental crop protection market segmented into turf grass and ornamental grass. Turf grass protection market accounted for larger revenue share in 2017 and projected to dominate over the forecast period owing to increase in the adoption of Bermuda grass, zoysia grass, and centipede grass due to the tolerance towards drought and adverse environmental conditions. However, ornamental grass protection segment projected exhibit lucrative growth, which is mainly attributed to increase the trend towards home grown lawns, ornamental plants enables create demand for pesticides in future.

North America leads the Global Turf and Ornamental Crop Protection market
PBI's global turf & ornamental crop protection market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. According to regional analysis, North America accounted for larger revenue share through 2012-2017 and the same trend is projected to follow over 2018-2023 owing to increase in the number of golf courses and sports grounds in the region.

To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/turf-and-ornamental-crop-protection-market/#ulp-c654SbFYO64MsOhu

Innovation of newer products, strong intellectual property portfolio, and strategic alliances are the key strategies adopted by market players

Global turf & ornamental crop protection market further reveals that the key players increasingly adopting strategies such as innovation of newer products and high number of patent filings, and long term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance, Dow Agrosciences has filed around 1,041 in U.S. and 4,603 worldwide till date in crop protection

Key player's profiles in the report are Syngenta AG (Switzerland), Dow AgroSciences LLC (U.S.), The Andersons Inc. (U.S.), Idemitsu Kosan Co. Ltd. (Japan), FMC Corporation (U.S.), Evans Turf Supplies Ltd. (New Zealand), Epicore BioNetworks Inc. (U.S.), Pure AG (U.S.), Eco Sustainable Solutions Ltd. (U.K.), CJB Industries, Inc. (U.S.), Sharda USA LLC, Martenson Turf Products, Inc. (U.S.)

Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/turf-and-ornamental-crop-protection-market/#ulp-14mlyhjMGhVjZqa3

Detailed Segmentation

By Grass Type
- Turf Grass
o Rye Grass
o Blue Kentucky Grass
o Zoysia Grass
o Tall Fescue
o Bermuda Grass
o Other Turf Grass

- Ornamental Grass
o Feather Reed Grass
o Fountain Grass
o Fibre Optic Grass
o Ravenna Grass
o Purple Millet
o Other Ornamental Grass

By Origin
- Organic
- Synthetic

By Product Type
- Insecticide
- Fungicide
- Herbicide
- Others

By Mode of Application
- Soil Treatment
- Foliar Spray
- Geography
-
Geography
- North America
o US
o Canada
- Europe
o Germany
o France
o UK
o Italy
o Spain
o Russia
o Poland
o Rest of Europe
- Asia-Pacific
o Japan
o China
o India
o Australia & New Zealand
o ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
o South Korea
o Rest of Asia-Pacific
- Latin America
o Brazil
o Mexico
o Argentina
o Venezuela
o Rest of Latin America
- Middle East and Africa (MEA)
o Gulf Cooperation Council (GCC) Countries
o Israel
o South Africa
o Rest of MEA

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/turf-and-ornamental-crop-protection-market/

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Global branded generics market estimated to be valued US$ 224.0 Bn in 2017 and poised to grow at CAGR 7.7 %. The market for branded generics projected to reach US$ 350.0 Bn by 2023.

London, UK -- (SBWIRE) -- 05/11/2018 -- Global Branded generics market report gives a comprehensive outlook on branded generics across the globe with special emphasis on key regions such as Asia-Pacific, Latin America, Middle East & Africa (MEA), North America, and Europe. Branded generics market report deals with deals with detailed market outlook in Emerging markets such as Brazil, Russia, China, India, and other Eastern Europe, Latin American countries. The report on branded generics market gives historical, current, and future market sizes (US$ Mn) on the basis of diseases Indication, route of administration, distribution channel, and geographic regions. This report studies branded generics market dynamics in emerging markets and developed markets elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, branded generics market report includes new product introductions, recent drug patent expiration data, regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed branded generics market to better equip clients with possible investment opportunities across the emerging markets (Regional Investment Hot-Spots) and market unmet needs (Product/Disease Opportunities). Key stakeholders of the branded generics market report include suppliers, manufacturers, marketers, policymakers engaged in manufacturing and supply of branded generics.

A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-branded-generics-market/#ulp-4H8Z4LpNMLEuOnnx

Branded Generics Market:

The branded generics market estimated to be valued US$ 224.0 Bn in 2017 and poised to grow at CAGR 7.7 %. The market for branded generics projected to reach US$ 350.0 Bn by 2023.

Increasing prevalence of chronic diseases such as diabetes, hypertension coupled with rising out-of-pocket healthcare expenditure driving the branded generics market revenue growth in developing regions

The market for branded generics expected to register around double-digit growth rate in emerging economies owing to the widespread prevalence of lifestyle and chronic diseases like diabetes and cardiovascular diseases. The growing lifestyle changes along with rising disposable income in middle classes are factors expected to prompt the market growth in near future. According to International Diabetes Federation (IDF) atlas, 2015 emerging nations like India and China, Brazil and Russia fall under top ten countries for diabetic population.

Rising patent expirations and a lull in developed pharmaceutical market growth

Developed pharmaceutical markets like North America, Europe, and Japan has been witnessing relatively slower market growth in comparing with developing markets owing to fewer new product approvals from the regulatory bodies and bleak late-stage pipeline. This has been led to the change in focus by several multinational pharmaceutical giants from matured markets to developing markets to tap ever-growing market opportunities in these regions. Moreover, increasing product patent expirations expected to boost the branded generics revenue growth in developing and mature markets across the globe.

Asia-Pacific accounts for larger market revenue share in global branded generics market

Asia-pacific expected to lead the global branded generics market in terms of revenue in over forecast period owing to higher out-of-pocket healthcare expenditure and lack of universal health coverage. Moreover, countries like India, China, and ASEAN countries presented better growth opportunities for the existing and new players in the market. Regions such as Asia Latin America and Eastern Europe projected to grow at significant CAGR over the forecast period

To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-branded-generics-market/#ulp-c654SbFYO64MsOhu

Competition Assessment

Key players profiled in the global branded generics market include:
- Abbott Laboratories (U.S.)
- Apotex Inc. (Canada)
- AstraZeneca (U.K)
- Reddy's Laboratories Ltd. (India)
- GlaxoSmithKline plc (U.K)
- Mylan N.V. (U.S.)
- Pfizer Inc. (U.S)
- Novartis AG (Switzerland)
- Sanofi (France)
- Sun Pharmaceutical Industries Ltd. (India)
- Teva Pharmaceutical Industries Ltd (Israel)
- Valeant Pharmaceuticals International, Inc. (Canada)
Market players are focusing on mergers and acquisitions, strategic alliances, and product diversification to increase the geographic presence in global branded generics market. Moreover, players are entering into a distribution agreement with local pharmaceutical companies to overcome the market access barrier in developing regions.

Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/global-branded-generics-market/#ulp-14mlyhjMGhVjZqa3

Key Findings of the Report:

- Branded Generics market expanding at 7.7% CAGR over 2017 to 2023 to reach market value of US$ 350.0 Bn by 2023 owing increase in prevalence of chronic and lifestyle disease in emerging markets
- Based on diseases Indication, cardiovascular diseases sub-segment projected to garner larger market revenue share in over forecast period owing to rising co-morbidities like diabetes and cardiovascular diseases
- Hospital and retail pharmacies are prime distribution channels for branded generics across the regions owing to accessibility and availability drugs
- Players focusing on increasing geographic foot-prints to garner growing market opportunities in developing countries

Key Features of the Report:

- The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
- The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup's details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market

Detailed Segmentation

By Diseases Indication
- Cardiovascular Diseases
- Diabetes
- Cancer
- Neurological Disorders
- Gastrointestinal Diseases
- Dermatology Diseases
- Others

By Route of Administration
- Oral
- Parenteral
- Topical
- Others

By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Online Pharmacies

Geography
- North America
o U.S.
o Canada
- Europe
o Germany
o France
o UK
o Italy
o Spain
o Russia
o Poland
o Rest of Europe
- Asia-Pacific
o Japan
o China
o India
o Australia & New Zealand
o ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
o South Korea
o Rest of Asia-Pacific
- Latin America
o Brazil
o Mexico
o Argentina
o Venezuela
o Rest of Latin America
- Middle East and Africa (MEA)
o Gulf Cooperation Council (GCC) Countries
o Israel
o South Africa
o Rest of MEA

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-branded-generics-market/

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Dermal Fillers Market Was Valued around USD 3.2 Billion in 2017, Wider Acceptance and Popularity Among Young Generation Driving The Market Revenue Growth

London, UK -- (SBWIRE) -- 05/09/2018 -- Precision Business Insights (PBI) in its report titled "Global Dermal Fillers Market: Market Estimation, Dynamics, Segment Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2023" assesses the market performance over six years forecast period. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

Dermal fillers are implants that are regulated as the medical devices by U.S.FDA. Dermal fillers are used as effective treatment for folds correction, wrinkles and deep lines on the face. Dermal fillers can be used for anti-aging practices to remove folds and wrinkles in nasolabial, and cheek area, lines and wrinkles around eye and volume loss in chin. Dermal fillers are the injectable gels that are composed of synthetic and natural substances like hyaluronic acid. Dermal fillers pump and lift the sagged skin for restoring lost collagen because of the aging.

Increase in patients with different cosmetic skin issues like deep lines, wrinkles and scars, diet imbalance are the major factors boosting the revenue growth of the dermal fillers market. As per the World Health Organization (WHO), more than 2 Bn of the global population will be over the age of 60 by the year 2050, WHO stated that the growth of the facial filler market is directly proportional to the growing geriatric population, who experience loss of fluid and collagen in the skin as they grow older, that results in the development of wrinkles on the face and neck areas. Dermal fillers is less painful and non-invasive method for treating various facial problems and aesthetic treatments for other parts of the body. High cost of the procedure and infections associated with dermal fillers is the major market constraint that hinders the growth of the dermal fillers market over the forecast period.

A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-dermal-fillers-market/#ulp-4H8Z4LpNMLEuOnnx

Derma fillers market segmented on the basis of product type, ingredient and distribution channel

On basis of product type, the dermal fillers market is segmented into
- Absorbable Dermal Fillers
- Non-Absorbable Dermal Fillers

On basis of ingredient, the dermal fillers market is segmented into
- Hyaluronic acid (HLA)
- Poly-L-Lactic Acid (PLA)
- Calcium hydroxyl apatite (CaH)
- Polymethylmethacrylate (PMMA)
- Collagen
- Others

On basis of distribution channel, the dermal fillers market is segmented into
- Retail Pharmacies
- Drug Stores
- Beauty Clinics
- Online Pharmacies

To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-dermal-fillers-market/#ulp-c654SbFYO64MsOhu

The global dermal filler market is expected to grow at significant rate owing to advances in technologies such as injecting techniques and molecular changes adopted in filler materials have brought safe and simple methods in performing dermal fillers to patients. Further, the market is witnessing various acquisitions, collaborations, and mergers among major players. A NAMCS (The National Ambulatory Medical Care Survey) reported that from 1995 to 2003, soft tissue fillers 18.4% constituted office-based cosmetic procedure visits. 90% of office-based cosmetic procedures were performed on Caucasian patients and 10% on non-Caucasian patients. The American Society of Plastic Surgeons in its 2007 Cosmetic Demographics by Patient Ethnicity reported that injectable fillers are one of the three most commonly adopted procedures among, Hispanics, Asian Americans, and African-Americans who seeks cosmetic procedures. As per to the statistics of the American Society of Aesthetic Plastic Surgery, in 2015, dermal filler cosmetic treatments has increased by 8%.

Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/global-dermal-fillers-market/#ulp-14mlyhjMGhVjZqa3

Based on the geographical regions dermal filler market is segmented into five key regions Latin America, North America, Asia-Pacific, Europe, Middle East and Africa. North America holds largest share globally followed by Europe, and Asia Pacific due to the high occurrence of various skin problems. In Asia-Pacific, the Australian and Chinese markets for facial injectable will sustain the fastest growth through 2014. The Asia-Pacific facial injectable market comprising sales of hyaluronic acid (HA) dermal fillers, particle and polymer fillers (PPFs), and collagen fillers will grow significantly due to increased physician adoption of profitable facial injectable treatments in their practices and growing patient demand for less invasive cosmetic procedures.

Some of the players in the dermal fillers market are Galderma (Nestle) (Switzerland), Bioha Laboratories (China), MERZ PHARMA GMBH & CO. KGAA (Germany), Syneron Inc.(U.S.), Allergan plc (Ireland), AQTIS Medical (Canada), and Suneva Medical (U.S.)

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-dermal-fillers-market/

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

London, UK -- (SBWIRE) -- 05/04/2018 -- Precision Business Insights (PBI) in its report titled "Global veterinary practice management software market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024" assesses the market performance over six years forecast period over 2018-2024. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

Availability of state-of-art software attracts customers for veterinary practice management software market.

Increasing number of firms providing animal healthcare software in order to offer better management, increased adoption of veterinary software services is expected to fuel the market. Innovative technologies and expanded applications to the veterinary healthcare are anticipated to create lucrative opportunities over forecast period.

A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-veterinary-practice-management-software-market/#ulp-4H8Z4LpNMLEuOnnx

North America has expected to account for major revenue share of global veterinary practice management software market

U.S. veterinary practice management software is accounted for significant regional revenue share due to surge in adoption of companion animal. Veterinary healthcare providers are inclining towards innovative software solutions to offer better disease management, customer relationship management. UK, Germany are cumulatively contributes significant market share in Europe. Improved veterinary healthcare infrastructure, increased adoption of advanced technologies in veterinary clinics and hospitals are expected to accelerate the market share in future. Increased pet adoption, rising disposable income in China create healthy opportunities. Emerging nations India, Mexico are expected to offer growth opportunities for global veterinary practice management software market over the forecast period.

To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-veterinary-practice-management-software-market/#ulp-c654SbFYO64MsOhu

Competition Assessment

Key players' profiles in the global veterinary practice management software market include:
- Vet Space Ltd. (UK)
- Computer Fanatics Limited (New Zealand)
- IDEXX Laboratories, Inc. (U.S.)
- Patterson Companies, Inc. (U.S.)
- Henry Schein, Inc. (U.S.)
- ezyVET Limited (New Zealand)
- Onward Systems Inc. (U.S.)
- ClienTrax, Inc. (U.S.)
- Alisvet & InformaVet Inc. (Canada)
- 2i Nova, Inc.(U.S.)
- Eclipse Veterinary Software Ltd (UK)
- Animal Intelligence Software, Inc. (U.S.)
- Hippo Manager Software, Inc. (U.S.)
- Timeless Veterinary Systems, Inc. (Canada)
- Firmcloud Corporation (U.S.)
- InformaVet Inc. (U.S.)

Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/global-veterinary-practice-management-software-market/#ulp-14mlyhjMGhVjZqa3

Key Findings of the Report:

- Veterinary practice management software market is expanding at XX% CAGR over 2017 to 2023 to reach market value of US$ XX Mn by 2023.

- Based on delivery mode, cloud based market is expanding at highest CAGR over the forecast period.

- Based on region type, North America is expected to account for major market share.

- Veterinary hospitals are prime channel for practice management software systems distribution across the globe

- Players focusing on expanding geographic presence to garner market opportunities in developing economies

Key Features of the Report:

- The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)

- The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies

- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

- The report tracks recent innovations, key developments and startup's details that are actively working in the market

- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market.

Detailed Segmentation

By Delivery Type
- Cloud based
- Web based
- Others

By Animal

- Small animal
- Large animals
- Others

By Distribution Channel

- Veterinary hospitals
- Veterinary clinics
- Others

By Geography

- North America
o U.S.
o Canada

- Europe
o Germany
o France
o UK
o Italy
o Spain
o Russia
o Poland
o Rest of Europe

- Asia-Pacific
o Japan
o China
o India
o Australia & New Zealand
o ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
o South Korea
o Rest of Asia-Pacific

- Latin America
o Brazil
o Mexico
o Argentina
o Venezuela
o Rest of Latin America

- Middle East and Africa (MEA)
o Gulf Cooperation Council (GCC) Countries
o Israel
o South Africa
o Rest of MEA

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-veterinary-practice-management-software-market/

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

London, UK-- (SBWIRE) -- 05/02/2018 -- Global Drugs of Abuse Testing Market

Drugs of Abuse Testing is used to determine one or more prescription or illegal drugs that present in the biological samples of a patient. Drugs of abuse are the illicit drugs that are taken for non-medical purposes.

Technological advancements of analyzers, rise in availability of forbidden drugs, increase in emphasis on work place screening propels the market growth of drugs of abuse testing market. Furthermore, rise in number of clinical laboratories offering tests for drugs of abuse, increase in demand for drug of abuse testing from private employers also drives the market for drug of abuse testing market globally. However, unfavorable reimbursement policies, low threshold of drug abuse testing laws in emerging countries may hamper the growth of the drug of abuse testing market globally.

A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/drugs-of-abuse-testing-market/#ulp-4H8Z4LpNMLEuOnnx

Drugs of Abuse Testing market is segmented based on the Drug, Test Type, Sample, End User and geographical regions
Based on the Drug, the market is segmented into the following:
- Narcotic
- Sedatives
- Psychostimulants
- Hallucinogens
- Others
Based on the Test Type, the market is segmented into the following:
- Chromatography
- Immunoassay
- Rapid Testing
Based on the Sample, the market is segmented into the following:
- Hair
- Saliva
- Urine
- Others
Based on the End User, the market is segmented into the following:
- Diagnostic Centers
- Forensic Labs
- Hospitals
Based on the Geographical Regions, the market is segmented into the following:
- North America
- Europe
- Asia Pacific
- Latin America
- The Middle East and Africa

To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/drugs-of-abuse-testing-market/#ulp-c654SbFYO64MsOhu

Currently, drug abusing is a major problem which is negatively impacting huge population globally. People who are addicted to alcohol or who are prescribed with prolonged usage of drugs are more prone to chronic diseases which are prevailing among global population that leads to economic burden on the nation. Hence, governments across the world are actively taking part in various initiatives to create awareness among people regarding prevention, eradication and early detection of drug abuse. However, companies are focusing on new product launches, minimizing the price of the tests in order to gain maximum traction in the global market. Furthermore, market players are concentrating on various growth strategies such as collaborations, acquisitions, partnerships to enhance their market presence.

Geographically, global Drugs of Abuse Testing market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America holds largest position in Drugs of Abuse Testing market globally especially U.S followed by European countries owing to the increase in availability of illicit drugs, rise in drug trafficking etc. As per to the National Institute of Drug Abuse, around 24.6 Mn Americans with age above 12 years used illicit drug. Asia Pacific, Latin America and MEA regions are also anticipated to have lucrative growth in Drugs of Abuse Testing market owing to the economic instability, un organized government regulations, lack of awareness regarding the usage of drugs, less literacy rates compared to developed countries, increase in adoption of western lifestyle etc.
.
Some of the players in the global Drugs of Abuse Testing market include:
- Siemens Healthineers (Germany)
- Thermo Fisher Scientific Inc. (U.S.)
- Draegerwerk AG & Co. KGaA, (Germany)
- Hoffmann-La Roche Ltd. (Switzerland)
- Danaher Corporation (Beckman Coulter, Inc.) (U.S.)
- Laboratory Corporation of America Holdings (U.S.)
- Abbott Laboratories (U.S.)

Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/drugs-of-abuse-testing-market/#ulp-14mlyhjMGhVjZqa3

Key Features of the Report:
- The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)
- The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup's details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/drugs-of-abuse-testing-market/

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

The Africa Animal Feed Market poised to reach US$ 37,594.5 Mn by 2023 with a significant CAGR over six years forecast period 2018-2023 owing to increase in the production of animal feed in African countries

London, UK -- (SBWIRE) -- 04/30/2018 -- Precision Business Insights (PBI) in its report titled "Africa Animal Feed Market: Market Estimation, Dynamics, Country Share, Trends, Competitor Analysis 2012-2017 and Forecast 2018-2023" assesses the market performance over six years forecast period. The report analyses the market value and volume forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over the forecast period.

The Africa Animal Feed market was valued at US$ 17,697.1 Mn in 2017 and projected to reach US$ 37,594.5 Mn by 2023 owing to increase in the production of animal feed in African countries due to availability of raw materials, for instance, maize is used in the manufacturing of animal feed is a major crop for African countries, rise in the demand for healthy meat and other livestock products, launch of novel animal feed products, and entry of market players into Africa region are anticipated to propel the Africa animal feed market. However, increase in the preference for natural feed products in the rural area, the high cost of animal feed products and lack of disease awareness in underdeveloped countries are expected to hinder the growth of Africa animal feed market over the forecast period.

A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/africa-animal-feed-market/#ulp-4H8Z4LpNMLEuOnnx/

Africa Animal Feed market segmented on the basis of feed type, animal type, and country

Medicated feed accounted for higher revenue share

Based on feed type Africa animal feed market segmented into medicated feed and non-medicated feed. Medicated feed accounted for larger revenue share in 2017 and projected to dominate over the forecast period owing to rise in the incidence of various livestock diseases. However, non-medicated feed segment projected exhibit lucrative growth, which is mainly attributed to increase the focus towards the production of high-quality meat and other livestock products by livestock farmers.

South Africa leads the Africa animal feed market

PBI's Africa Animal Feed market report analyses the market in different countries such as Angola, Botswana, Congo (DR), Lesotho, Malawi, Mauritius, Mozambique, Namibia, Seychelles, South Africa, Swaziland, Tanzania, Zambia, Zimbabwe, and Kenya. According to country analysis, South Africa accounted for larger value and volume share through 2012-2017 and the same trend is projected to follow over 2018-2023 owing the to the presence of key players in the country. Kenya, Zambia, and Zimbabwe countries projected to exhibit significant growth owing to increase in the population demanding for healthy meat and other livestock products.

To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/africa-animal-feed-market/#ulp-c654SbFYO64MsOhu/

Feed mills establishment, customized product launches, and strategic alliances are the key strategies adopted by market players

Africa animal feed market further reveals that the key players increasingly adopting strategies such as feed mills extension, customized product launches, and long-term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance, in May 2017, Biomar group launched a complete, high-performing feed range for African catfish and tilapia for the African market.

Key player's profiles in the report are Cargill, Inc. (U.S), Nutreco N.V. (Netherlands), BASF SE (Germany), Koninklijke DSM N.V. (Netherlands), Novus International (U.S), Biomin Holding GmbH (Austria)

Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/africa-animal-feed-market/#ulp-14mlyhjMGhVjZqa3/

Detailed Segmentation
By Feed Type
- Medicated Feed
o Broilers Medicated Feed
o Layers Medicated Feed
o Dairy Medicated Feed
o Beef Medicated Feed
o Swine Medicated Feed
o Others Medicated Feed
- Non-medicated Feed
o Broilers Non-medicated Feed
o Layers Non-medicated Feed
o Dairy Non-medicated Feed
o Beef non-medicated Feed
o Swine Non-medicated Feed
o Others Non-medicated Feed

By Animal Type
- Farm Animals
o Broilers
o Layers
o Dairy
o Beef
o Swine
o Others
- Aquaculture
- Others

By Geography
- Africa
o Angola
o Botswana
o Congo (DR)
o Lesotho
o Malawi
o Mauritius
o Mozambique
o Namibia
o Seychelles
o South Africa
o Swaziland
o Tanzania
o Zambia
o Zimbabwe
o Kenya

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/africa-animal-feed-market/

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI's approachable strategies are to help clients to make key decisions for business growth.

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

Contact to Precision Business Insights,

Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Global feed antioxidants market poised to reach USD 432.6 Mn by 2023 with CAGR of 4.2% over six years forecast period 2017-2023 owing to increased surge in the trend towards compounded feed.

Barcelona, Spain -- (SBWIRE) -- 04/26/2018 -- Precision Business Insights (PBI) in its report titled "Global Feed Antioxidants Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023" assesses the market performance over six years forecast period over 2017-2023. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

The global feed antioxidants market was valued at USD 324.5 Mn in 2016 and projected to reach USD 432.6 Mn by 2023 owing to growing production and consumption livestock products and increase in farming activities across the region, increase in per capita meat consumption, rapid increase in meat industry is expected to enhance the livestock production. Rising awareness of qualitative feed for the livestock anticipated to increase the market for feed antioxidants over the forecast period.

A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-feed-antioxidants-market/#ulp-4H8Z4LpNMLEuOnnx/

Global feed antioxidants market segmented on the basis of antioxidant type, feed type and geography

The natural antioxidants are witnessed to gain traction over synthetic antioxidants due to less hazardous effects compared to synthetic antioxidants

The surge in awareness among pet owners regarding carcinogen effects of synthetic antioxidants is expected to accelerate the demand for natural antioxidants over the forecast period. The natural antioxidants are expected to drive the feed antioxidants market growth due to cost effectiveness of the products.

Asia Pacific feed antioxidants market accounted for larger revenue share in global market due to increase in demand and low manufacturing cost in the region compared to other regions

PBI's global feed antioxidants market report analyses the market in different geographies such as North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. According to regional analysis, Asia Pacific accounted for larger revenue share through 2012-2016 and the same trend is projected to follow over 2017-2023. Asia-Pacific region projected to exhibit highest growth among all regions owing to growing animal rearing and livestock production.

To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-feed-antioxidants-market/#ulp-c654SbFYO64MsOhu/

Product Launches, M&A, Partnerships, and collaborations are the key strategies adopted by market players

Global Feed Antioxidants market further reveals that the key players increasingly adopting M&A, Partnerships, and collaborations strategies to improve economies of scale by increasing manufacturing capacities and gaining significant geographic presence across the regions.

For instance, in September 2017, Kemin Industries, was granted a patent for its antioxidant formulation technology which is the basis for the Paradigmox antioxidant brand. Paradigmox, which uses the novel antioxidant formulation technology, has been available to animal feed for several years. The solution provides equal efficacy to ethoxyquin in diverse feed applications.

Key player's profiles in the report are Kemin Industries, Inc. (U.S.), BASF SE (Germany), Archer Daniels Midland Company (U.S.), Cargill Inc. (U.S.), Nutreco N.V. (Netherlands), Alltech Inc. (U.S.), Novus International (U.S.), Perstorp Holding AB (Sweden), Adisseo France S.A.S. (France), Oxiris (Spain), and Dupont Nutrition and Health (Danisco) (Denmark)

Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/global-feed-antioxidants-market/#ulp-14mlyhjMGhVjZqa3/

Detailed Segmentation

By Antioxidant Type
- Natural
o Rosemary Extract
o Tocopherols
o Gallic Acid
o Oil Seeds
o Corn
o Rapeseeds
o Others
- Synthetic antioxidants
o Ethoxyquin
o BHT
o BHA
o Vitamin E
o Propyl Gallate
o Others

By Feed Type
- Broilers Pre-starter Feed
- Piglets Pre-starter Feed
- Cattle Pre-starter Feed
- Aqua Pre-starter Feed
- Pet Food
- Cattle Feed
- Poultry Feed
- Aqua Feed
- Pig Feed
- Feed Premixes
- Raw Material

Geography
- North America
o U.S
o Canada
- Europe
o Germany
o France
o U.K
o Italy
o Spain
o Russia
o Poland
o Rest of Europe
- Asia-Pacific
o Japan
o China
o India
o Australia & New Zealand
o ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
o South Korea
o Rest of Asia-Pacific
- Latin America
o Brazil
o Mexico
o Argentina
o Venezuela
o Rest of Latin America
- Middle East and Africa (MEA)
o Gulf Cooperation Council (GCC) Countries
o Israel
o South Africa
o Rest of MEA

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-feed-antioxidants-market/

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

The U.K private healthcare market estimated to be valued US$ 11.8 Bn in 2017 and poised to grow at CAGR of 2.6% over 2017 to 2023. The market for private healthcare services projected to reach US$ 13.8 Bn by 2023 due to rise in NHS waiting times and referrals to the private sector.

London, UK -- (SBWIRE) -- 04/24/2018 -- Rise in self-pay individuals coupled with overseas patients expected to fuel market growth

In recent times patients in the country increasingly preferring private healthcare services over NHS devices for elective procedures and several non-urgent services owing to rise in NHS waiting lists and packaged pricing form private healthcare providers. This is expected to fuel market revenue growth in near future. Moreover, this trend has been well capitalized by service providers by mean of offering packaged and discounted prices along with fixed consultant fees to attract the patients, which is expected to drive the market revenue growth over the forecast period.

A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/u-k-private-healthcare-market/#ulp-4H8Z4LpNMLEuOnnx

A rise in NHS waiting list and e-Referrals from GPs driving market growth

The rise in the waiting list in recent times for several ailments in NHS is prompting patients to choose private healthcare services over NHS services. The rise in NHS waiting time more than 18 weeks for treatment is expected to bolster private healthcare market in the UK. Moreover, flexibility in GP referrals where, patients can opt for desired time, date, and hospital/clinic for consultation, which is creating a market opportunity for the players in U.K private healthcare market. According to NHS, the numbers of patients waiting for NHS services are growing in recent times.
Mute in growth of PMI expected to hinder market revenue growth

The decline in private medical insurance uptake in last few years and decreasing pay-out to clinics and hospitals for healthcare services by insurance providers expected to hinder market revenue growth in the midterm. Moreover, ongoing decline in inpatient and day caseload is currently hindering the market growth and relatively fewer companies offer medical benefits after retirement which could hinder market revenue growth of private healthcare market in U.K

To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/u-k-private-healthcare-market/#ulp-c654SbFYO64MsOhu

Competition Assessment

Key players profiled in the U.K private healthcare market include:
- Aspen Healthcare (A Sub. Of Tenet Healthcare)
- BMI Healthcare
- Bupa Cromwell Hospital
- Care UK
- CIRCLE HOLDINGS PLC
- HCA Management Services, L.P.
- Nuffield Health
- Ramsay Health Care
- Spire Healthcare Group Plc.

Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/u-k-private-healthcare-market/#ulp-14mlyhjMGhVjZqa3

Market players are focusing on providing package and fixed consultation charges to acquire the larger market share in U.K private healthcare market. Moreover, the market is consolidated in nature with few players holding larger revenue share in the market.

Key Findings of the Report:

- U.K private healthcare market expanding at 2.6% CAGR over 2017 to 2023 to reach market value of US$ 13.8 Bn by 2023 owing to rising NHS waiting lists
- Based on service type private acute care hospitals accounted for larger market share in 2016 and projected to remain dominant over the forecast period
- Self-pay Individuals end-user segment accounted for larger market revenue share in 2016 and projected to remain dominant over the forecast period due to rise in out-of-pocket healthcare service expenditure
- Players focusing on packages and fixed consultation charges to the patients to garner larger market opportunities.
Key Features of the Report:

- The report provides granular level information about the market size, market share, historic market (2012-2016) and forecast (2017-2023)
- The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup's details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market
Detailed Segmentation

By Service Type
- Private Acute Care Hospitals
- Private Patient Care Clinics
- Private Specialist Services
- Private Diagnostics and Imaging Centers
- Private Urgent Care Centers
- Others

By Specialty
- Trauma and Orthopedics
- General Surgery
- Oncology
- Maternity and OB-Gyn
- Cardiology
- Urology
- Others

By End Users
- International Tourists
- NHS Referrals & PMI
- Self-pay Individuals

By Country
U.K

Get full summery@
https://www.precisionbusinessinsights.com/market-reports/u-k-private-healthcare-market/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm